euspongia officinalis (spongia) golyócskák (d 4)
remedia homöopathie gmbh - euspongia officinalis -
euspongia officinalis (spongia) golyócskák (d 6)
remedia homöopathie gmbh - euspongia officinalis -
euspongia officinalis (spongia) golyócskák (d 12)
remedia homöopathie gmbh - euspongia officinalis -
euspongia officinalis (spongia) golyócskák (d 30)
remedia homöopathie gmbh - euspongia officinalis -
euspongia officinalis (spongia) golyócskák (d 200)
remedia homöopathie gmbh - euspongia officinalis -
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, 2. típus - cukorbetegségben szedett gyógyszerek - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5. és 5. sz. 1 a rendelkezésre álló adatokra a különböző kombinációk esetén).
lutetium (177lu) chloride billev (previously illuzyce)
billev pharma aps - lutetium (177lu) chloride - radionuklid képalkotás - terápiás radiofarmakonok - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, 2. típus - cukorbetegségben szedett gyógyszerek - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , hármas kombinációs terápia) kiegészítéseként javasolt diéta, testmozgás, a betegek nem megfelelően ellenőrzött a maximálisan tolerálható dózis a metforminnal, illetve a szulfonilureával. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sodium salicyl 80% wsp, por belsoleges oldathoz szarvasmarhák (borjak) és sertések részére a.u.v.
dopharma research b.v. - nátrium-szalicilát - por belsoleges oldathoz - sodium salicylate - szarvasmarha, sertés
anastrozole usp pharma 1 mg filmtabletta
usp pharma life sciences sp. zo.o. - anasztrozol -